Benign lymphoepithelial lesion

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

WikiDoc Resources for Benign lymphoepithelial lesion
Articles
Most recent articles on Benign lymphoepithelial lesion Most cited articles on Benign lymphoepithelial lesion Review articles on Benign lymphoepithelial lesion Articles on Benign lymphoepithelial lesion in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Benign lymphoepithelial lesion Images of Benign lymphoepithelial lesion Photos of Benign lymphoepithelial lesion Podcasts & MP3s on Benign lymphoepithelial lesion Videos on Benign lymphoepithelial lesion
Evidence Based Medicine
Cochrane Collaboration on Benign lymphoepithelial lesion Bandolier on Benign lymphoepithelial lesion TRIP on Benign lymphoepithelial lesion
Clinical Trials
Ongoing Trials on Benign lymphoepithelial lesion at Clinical Trials.gov Trial results on Benign lymphoepithelial lesion Clinical Trials on Benign lymphoepithelial lesion at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Benign lymphoepithelial lesion NICE Guidance on Benign lymphoepithelial lesion NHS PRODIGY Guidance FDA on Benign lymphoepithelial lesion CDC on Benign lymphoepithelial lesion
Books
Books on Benign lymphoepithelial lesion
News
Benign lymphoepithelial lesion in the news Be alerted to news on Benign lymphoepithelial lesion News trends on Benign lymphoepithelial lesion
Commentary
Blogs on Benign lymphoepithelial lesion
Definitions
Definitions of Benign lymphoepithelial lesion
Patient Resources / Community
Patient resources on Benign lymphoepithelial lesion Discussion groups on Benign lymphoepithelial lesion Patient Handouts on Benign lymphoepithelial lesion Directions to Hospitals Treating Benign lymphoepithelial lesion Risk calculators and risk factors for Benign lymphoepithelial lesion
Healthcare Provider Resources
Symptoms of Benign lymphoepithelial lesion Causes & Risk Factors for Benign lymphoepithelial lesion Diagnostic studies for Benign lymphoepithelial lesion Treatment of Benign lymphoepithelial lesion
Continuing Medical Education (CME)
CME Programs on Benign lymphoepithelial lesion
International
Benign lymphoepithelial lesion en Espanol Benign lymphoepithelial lesion en Francais
Business
Benign lymphoepithelial lesion in the Marketplace Patents on Benign lymphoepithelial lesion
Experimental / Informatics
List of terms related to Benign lymphoepithelial lesion

Benign lymphoepithelial lesion is a type of benign enlargement of the parotid and/or lacrimal glands. This pathologic state is sometimes, but not always, associated with Sjögren's syndrome.

Historically, bilateral parotid and lacrimal gland enlargement was characterized by the term Mikulicz's disease if the enlargement appeared apart from other diseases. If it was secondary to another disease, such as tuberculosis, sarcoidosis, lymphoma, and Sjögren's syndrome, the term used was Mikulicz's syndrome. Both names derive from Jan Mikulicz-Radecki, the Polish surgeon best known for describing these conditions. Today, the terms "Mikulicz's disease" and "Mikulicz's syndrome" are viewed as ambiguous and outdated.

Locations

Occurring in 80% of cases, the gland most likely to be affected is the parotid gland. Lacrimal glands are also affected.

Characteristic

Benign lymphoepithelial lesion is most likely to occur in adults around 50 years of age. There is a predilection for gender with 60% - 80% being female. The gland affected has a diffuse swelling. The swelling can be asymptomatic, but mild pain can also be associated.

Most cases of benign lymphoepithelial lesions appear in conjunction with Sjögren's syndrome. When Sjögren's syndrome is present, the swelling is usually bilateral. Otherwise, the affected glands are usually only on one side of the body.

In most cases, a biopsy is needed to distinguish benign lymphoepithelial lesions from sialadenosis (sialosis).

Histology

There is a marked lymphoplasmacytic infiltration. Lymphoid follicles surround solid epithelial nests, giving rise to the 'epimyoepithelial islands', that are mainly composed of ductal cells with occasional myoepithelial cells. Excess hyaline basement membrane material is deposited between cells, and there is also acinar atrophy and destruction.

Treatment

Treatment usually consists of surgical removal of the affected gland. Prognosis is usually good, however occasionally this condition may evolve into lymphoma, or represent occult lymphoma from the outset.

References

• Kahn, Michael A. Basic Oral and Maxillofacial Pathology. Volume 1. 2001.
• Regezi, Joseph A. Oral Pathology: Clinical Pathologic Correlations. 4th ed. 2002.

External links

• Template:WhoNamedIt - "Mikulicz's disease"
• Mikulicz'+Disease at the US National Library of Medicine Medical Subject Headings (MeSH)
• K11.8 - ICD10
• Lee S, Tsirbas A, McCann J, Goldberg R (2006). "Mikulicz's disease: a new perspective and literature review". Eur J Ophthalmol. 16 (2): 199–203. PMID 16703534.CS1 maint: Multiple names: authors list (link)
• Ihrler S, Harrison J (2005). "Mikulicz's disease and Mikulicz's syndrome: analysis of the original case report of 1892 in the light of current knowledge identifies a MALT lymphoma". Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 100 (3): 334–9. PMID 16122662.

Template:Oral pathology